50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,705.50 (+1.38%)
DOW   29,606.32 (+1.18%)
QQQ   277.80 (+1.25%)
AAPL   154.18 (+2.26%)
MSFT   241.02 (+1.50%)
META   138.99 (+1.92%)
GOOGL   99.70 (+1.56%)
AMZN   117.88 (+2.37%)
TSLA   286.73 (+3.88%)
NVDA   126.77 (+3.67%)
NIO   17.98 (+2.04%)
BABA   79.63 (+0.91%)
AMD   68.55 (+3.39%)
T   15.86 (+1.21%)
MU   50.40 (+3.11%)
CGC   2.87 (+4.74%)
F   12.17 (+1.50%)
GE   64.96 (+0.95%)
DIS   99.39 (+1.29%)
AMC   7.30 (+6.88%)
PYPL   86.62 (+2.80%)
PFE   44.34 (+1.16%)
NFLX   229.52 (+2.43%)
S&P 500   3,705.50 (+1.38%)
DOW   29,606.32 (+1.18%)
QQQ   277.80 (+1.25%)
AAPL   154.18 (+2.26%)
MSFT   241.02 (+1.50%)
META   138.99 (+1.92%)
GOOGL   99.70 (+1.56%)
AMZN   117.88 (+2.37%)
TSLA   286.73 (+3.88%)
NVDA   126.77 (+3.67%)
NIO   17.98 (+2.04%)
BABA   79.63 (+0.91%)
AMD   68.55 (+3.39%)
T   15.86 (+1.21%)
MU   50.40 (+3.11%)
CGC   2.87 (+4.74%)
F   12.17 (+1.50%)
GE   64.96 (+0.95%)
DIS   99.39 (+1.29%)
AMC   7.30 (+6.88%)
PYPL   86.62 (+2.80%)
PFE   44.34 (+1.16%)
NFLX   229.52 (+2.43%)
S&P 500   3,705.50 (+1.38%)
DOW   29,606.32 (+1.18%)
QQQ   277.80 (+1.25%)
AAPL   154.18 (+2.26%)
MSFT   241.02 (+1.50%)
META   138.99 (+1.92%)
GOOGL   99.70 (+1.56%)
AMZN   117.88 (+2.37%)
TSLA   286.73 (+3.88%)
NVDA   126.77 (+3.67%)
NIO   17.98 (+2.04%)
BABA   79.63 (+0.91%)
AMD   68.55 (+3.39%)
T   15.86 (+1.21%)
MU   50.40 (+3.11%)
CGC   2.87 (+4.74%)
F   12.17 (+1.50%)
GE   64.96 (+0.95%)
DIS   99.39 (+1.29%)
AMC   7.30 (+6.88%)
PYPL   86.62 (+2.80%)
PFE   44.34 (+1.16%)
NFLX   229.52 (+2.43%)
S&P 500   3,705.50 (+1.38%)
DOW   29,606.32 (+1.18%)
QQQ   277.80 (+1.25%)
AAPL   154.18 (+2.26%)
MSFT   241.02 (+1.50%)
META   138.99 (+1.92%)
GOOGL   99.70 (+1.56%)
AMZN   117.88 (+2.37%)
TSLA   286.73 (+3.88%)
NVDA   126.77 (+3.67%)
NIO   17.98 (+2.04%)
BABA   79.63 (+0.91%)
AMD   68.55 (+3.39%)
T   15.86 (+1.21%)
MU   50.40 (+3.11%)
CGC   2.87 (+4.74%)
F   12.17 (+1.50%)
GE   64.96 (+0.95%)
DIS   99.39 (+1.29%)
AMC   7.30 (+6.88%)
PYPL   86.62 (+2.80%)
PFE   44.34 (+1.16%)
NFLX   229.52 (+2.43%)
NASDAQ:HRMY

Harmony Biosciences - HRMY Earnings Date, Estimates & Call Transcripts

$42.54
+0.48 (+1.14%)
(As of 09/27/2022 09:31 AM ET)
Add
Compare
Today's Range
$42.34
$42.54
50-Day Range
$42.06
$55.42
52-Week Range
$31.54
$57.13
Volume
204 shs
Average Volume
505,627 shs
Market Capitalization
$2.52 billion
P/E Ratio
44.78
Dividend Yield
N/A
Price Target
$60.33

Earnings Summary

Upcoming
Earnings Date
Nov. 8Estimated
Actual EPS
(Aug. 2)
$0.57 Beat By $0.17
Consensus EPS
(Aug. 2)
$0.40
Last Year's Q3 EPS
(8/9/2021)
$0.24
Skip Charts & View Estimated and Actual Earnings Data

HRMY Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

HRMY Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Harmony Biosciences Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20223$0.15$0.30$0.24
Q2 20223$0.33$0.42$0.37
Q3 20223$0.01$0.51$0.29
Q4 20223$0.39$0.60$0.47
FY 202212$0.88$1.83$1.37
Q1 20232$0.41$0.57$0.49
Q2 20232$0.56$0.69$0.63
Q3 20232$0.60$0.74$0.67
Q4 20232$0.66$0.76$0.71
FY 20238$2.23$2.76$2.50

HRMY Earnings Date and Information

Harmony Biosciences last posted its quarterly earnings data on August 2nd, 2022. The reported $0.57 earnings per share for the quarter, topping analysts' consensus estimates of $0.40 by $0.17. The firm had revenue of $107.03 million for the quarter, compared to analyst estimates of $99.35 million. Harmony Biosciences has generated $0.95 earnings per share over the last year ($0.95 diluted earnings per share) and currently has a price-to-earnings ratio of 44.8. Earnings for Harmony Biosciences are expected to grow by 96.99% in the coming year, from $1.33 to $2.62 per share. Harmony Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 8th, 2022 based off prior year's report dates.

Harmony Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
11/8/2022
(Estimated)
        
8/2/2022Q2 2022$0.40$0.57+$0.17$0.75$99.35 million$107.03 million    
5/3/2022Q1 2022$0.25$0.51+$0.26$0.67$87.77 million$85.31 million    
2/28/2022Q4 2021$0.32$0.63+$0.31$0.88$88.43 million$91.21 million    
11/8/20219/30/2021$0.29($0.17)($0.46)$1.03$79.30 million$80.73 million  
8/9/20216/30/2021$0.18$0.24+$0.06$0.84$70.85 million$73.82 million    
5/10/20213/31/2021($0.03)$0.38+$0.41$0.63$59.60 million$59.67 million  
3/24/202112/31/2020$0.09$0.25+$0.16$0.50$51.50 million$56.29 million  
11/17/20209/30/2020($0.05)($0.14)($0.09)($0.14)$40.10 million$45.61 million  












Harmony Biosciences Earnings - Frequently Asked Questions

When is Harmony Biosciences's earnings date?

Harmony Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 8th, 2022 based off last year's report dates. Learn more on HRMY's earnings history.

Did Harmony Biosciences beat their earnings estimates last quarter?

In the previous quarter, Harmony Biosciences (NASDAQ:HRMY) reported $0.57 earnings per share (EPS) to beat the analysts' consensus estimate of $0.40 by $0.17. Learn more on analysts' earnings estimate vs. HRMY's actual earnings.

How can I listen to Harmony Biosciences's earnings conference call?

The conference call for Harmony Biosciences's latest earnings report can be listened to online. Listen to Conference Call

How can I read Harmony Biosciences's conference call transcript?

The conference call transcript for Harmony Biosciences's latest earnings report can be read online. Read Transcript

How much revenue does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded annual revenue of $305.44 million.

How much profit does Harmony Biosciences generate each year?

Harmony Biosciences (NASDAQ:HRMY) has a recorded net income of $34.60 million. HRMY has generated $0.95 earnings per share over the last four quarters.

What is Harmony Biosciences's price-to-earnings ratio?

Harmony Biosciences (NASDAQ:HRMY) has a trailing price-to-earnings ratio of 44.78 and a forward price-to-earnings ratio of 31.98.

What is Harmony Biosciences's EPS forecast for next year?

Harmony Biosciences's earnings are expected to grow from $1.33 per share to $2.62 per share in the next year, which is a 96.99% increase.

More Earnings Resources from MarketBeat

Upcoming Earnings:
This page (NASDAQ:HRMY) was last updated on 9/27/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.